Latest Insider Transactions at Fibrogen Inc (FGEN)
This section provides a real-time view of insider transactions for Fibrogen Inc (FGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FIBROGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FIBROGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2023
|
Benjamin Cravatt |
SELL
Open market or private sale
|
Direct |
3,944
-6.22%
|
$67,048
$17.13 P/Share
|
|
Jun 09
2023
|
Jeffrey L Edwards |
SELL
Open market or private sale
|
Direct |
7,889
-9.89%
|
$134,113
$17.13 P/Share
|
|
Jun 08
2023
|
Jeffrey William Henderson Director |
SELL
Open market or private sale
|
Direct |
7,000
-8.66%
|
$119,000
$17.28 P/Share
|
|
Jun 08
2023
|
Maykin Ho |
SELL
Open market or private sale
|
Direct |
8,520
-11.12%
|
$144,840
$17.24 P/Share
|
|
Jun 07
2023
|
Suzanne Blaug |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+17.86%
|
-
|
|
Jun 07
2023
|
Aoife Brennan |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+20.23%
|
-
|
|
Jun 07
2023
|
Benjamin Cravatt |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+20.23%
|
-
|
|
Jun 07
2023
|
James A Schoeneck |
SELL
Open market or private sale
|
Indirect |
7,100
-8.78%
|
$127,800
$18.03 P/Share
|
|
Jun 07
2023
|
James A Schoeneck |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+22.37%
|
-
|
|
Jun 07
2023
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+16.53%
|
-
|
|
Jun 07
2023
|
Jeffrey L Edwards |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+16.53%
|
-
|
|
Jun 07
2023
|
Gerald Lema |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+22.37%
|
-
|
|
Jun 07
2023
|
Maykin Ho |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+17.16%
|
-
|
|
Jun 07
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
1,758
-0.78%
|
$29,886
$17.04 P/Share
|
|
Jun 07
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
3,633
-0.48%
|
$61,761
$17.04 P/Share
|
|
Jun 07
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,785
-1.23%
|
$28,560
$17.0 P/Share
|
|
Jun 07
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,897
-1.16%
|
$151,249
$17.04 P/Share
|
|
Jun 07
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,042
-1.24%
|
$34,714
$17.04 P/Share
|
|
Jun 02
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,090
-0.66%
|
$19,620
$18.83 P/Share
|
|
Apr 10
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,869
-0.49%
|
$35,511
$19.52 P/Share
|
|
Apr 04
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,182
-5.24%
|
$165,276
$18.78 P/Share
|
|
Apr 04
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
6,590
-2.54%
|
$118,620
$18.78 P/Share
|
|
Mar 23
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
905
-0.81%
|
$16,290
$18.71 P/Share
|
|
Mar 20
2023
|
Thane Wettig CEO |
BUY
Bona fide gift
|
Indirect |
1,000
+50.0%
|
-
|
|
Mar 20
2023
|
Thane Wettig CEO |
SELL
Bona fide gift
|
Direct |
2,343
-2.12%
|
-
|
|
Mar 10
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,140
-2.77%
|
$202,800
$20.2 P/Share
|
|
Mar 10
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,589
-3.86%
|
$631,780
$20.2 P/Share
|
|
Mar 10
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
7,606
-1.44%
|
$152,120
$20.2 P/Share
|
|
Mar 10
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
7,669
-3.27%
|
$153,380
$20.2 P/Share
|
|
Mar 10
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,912
-2.15%
|
$98,240
$20.2 P/Share
|
|
Mar 08
2023
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,183
+5.29%
|
-
|
|
Mar 08
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,363
-4.27%
|
$154,623
$21.16 P/Share
|
|
Mar 08
2023
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,349
+6.98%
|
-
|
|
Mar 08
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,672
-6.48%
|
$518,112
$21.16 P/Share
|
|
Mar 08
2023
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
15,137
+2.79%
|
-
|
|
Mar 08
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
8,354
-3.21%
|
$175,434
$21.16 P/Share
|
|
Mar 08
2023
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,137
+6.14%
|
-
|
|
Mar 08
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
6,265
-5.68%
|
$131,565
$21.16 P/Share
|
|
Mar 08
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,567
+4.74%
|
-
|
|
Mar 08
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,749
-3.77%
|
$57,729
$21.16 P/Share
|
|
Mar 02
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,187
-0.68%
|
$24,927
$21.87 P/Share
|
|
Feb 21
2023
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+8.78%
|
-
|
|
Feb 21
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.52%
|
-
|
|
Feb 21
2023
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.47%
|
-
|
|
Feb 21
2023
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+15.76%
|
-
|
|
Feb 21
2023
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,300
+18.3%
|
-
|
|
Jan 06
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,538
-0.52%
|
$29,222
$19.95 P/Share
|
|
Dec 23
2022
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
734
-0.82%
|
$11,010
$15.8 P/Share
|
|
Dec 12
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,407
-2.55%
|
$19,698
$14.5 P/Share
|
|
Dec 09
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
781
-1.4%
|
$10,934
$14.9 P/Share
|